Global /Japan /Healthcare /Drug Manufacturers - General /4554

Fuji Pharma Co., Ltd.

4554

• TSE: 4554 • Delayed

2,192JPY -2.2%

13.70 USD

As of 5 June 2026, Fuji Pharma Co., Ltd. has a market cap of $351.83M USD, ranking #17603 globally and #1315 in Japan. It ranks #1594 in the Healthcare sector, and #573 in the Drug Manufacturers - General industry.

Global Rank

17603

Country Rank

1315

Sector Rank

1594

Industry Rank

573

Key Stats

Market Cap

$351.83MUSD

56.3B JPY

Enterprise Value

$521.04MUSD

83.38B JPY

Revenue (TTM)

$341.03MUSD

54.57B JPY

EBITDA (TTM)

$66.01MUSD

10.56B JPY

Net Income (TTM)

$14.58MUSD

2.33B JPY

EBITDA Margin

19%

Profit Margin

4.3%

PE Ratio

23.0

Forward PE

14.9

PS Ratio

1.0

PB Ratio

1.2

EV/EBITDA

7.9

Company Profile

Country (HQ)

Japan

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Shuhei Morita open_in_new

Employees

1,760

Founded

1965

Website

fujipharma.jp open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.2%	-7.9%	-13%	13%	31%	16%	62%	78%	82%

News

Markets

Exchange	Ticker	Price	Quotes
Tokyo Stock Exchange (TSE / TYO) MIC: XTKS PRIMARY	4554 富士製薬工業 ISIN: JP3816200004 Shares Out.: Shares Outstanding: 26.12M¹ Shares Float: 13.48M² TV: TradingView: TSE: 4554 SA: Stock Analysis: TYO: 4554 YF: Yahoo Finance: 4554.T GF: Google Finance: TYO: 4554 BA: Barron's: 4554 MS: Morningstar: XTKS: 4554	2,192 JPY	TV: TradingView: TSE: 4554 SA: Stock Analysis: TYO: 4554 YF: Yahoo Finance: 4554.T GF: Google Finance: TYO: 4554 BA: Barron's: 4554 MS: Morningstar: XTKS: 4554
Frankfurt Stock Exchange (FRA) MIC: XFRA	FUP 富士製薬工業 ISIN: JP3816200004 TV: TradingView: FWB: FUP SA: Stock Analysis: FRA: FUP YF: Yahoo Finance: FUP.F GF: Google Finance: FRA: FUP BA: Barron's: FUP MS: Morningstar: XFRA: FUP	11.90 EUR	TV: TradingView: FWB: FUP SA: Stock Analysis: FRA: FUP YF: Yahoo Finance: FUP.F GF: Google Finance: FRA: FUP BA: Barron's: FUP MS: Morningstar: XFRA: FUP

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Fuji Pharma Co., Ltd.

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.

Similar Companies

Industry: Drug Manufacturers - General (Japan)

Name	Market Cap (USD) diff.	PE	Country
Chugai Pharmaceutical Co., Ltd. TSE: 4519	$81.66B 13.07T JPY 23K%	28.9	Japan
Takeda Pharmaceutical Company Ltd. TSE: 4502	$52.21B 8.36T JPY 15K%	75.1	Japan
Otsuka Holdings Co., Ltd. TSE: 4578	$36.84B 5.9T JPY 10K%	15.7	Japan
Daiichi Sankyo Company, Ltd. TSE: 4568	$30.37B 4.86T JPY 9K%	16.2	Japan
Astellas Pharma Inc. TSE: 4503	$25.82B 4.13T JPY 7K%	14.2	Japan
Shionogi & Co., Ltd. TSE: 4507	$16.91B 2.71T JPY 5K%	13.9	Japan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 216K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 155K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 102K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 92K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 82K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 79K%	20.5	Switzerland

chevron_leftBack